Table III.
Correlation between serum hs-CRP concentration and AFP status, TNM stage and tumor Edmondson grading in hepatocellular carcinoma patients.
| Parameter | n | hs-CRP concentration, mg/l | r | P-value |
|---|---|---|---|---|
| AFP status | 0.336 | 0.737 | ||
| AFP negative | 65 | 15.51±22.016 | ||
| AFP positive | 122 | 17.24±22.044 | ||
| TNM stage | 0.238 | 0.229 | ||
| I | 40 | 18.24±19.39 | ||
| II | 69 | 19.37±21.06 | ||
| III | 45 | 20.40±26.37 | ||
| IV | 33 | 32.71±32.41 | ||
| Edmondson grading | 0.159 | 0.498 | ||
| Early stages (I–II) | 109 | 19.02±19.81 | ||
| Advanced stages (III–IV) | 78 | 24.02±27.82 |
The diagnostic cutoff values of AFP was 20 ng/l. Data are presented as the mean ± standard deviation. hs-CRP, high-sensitivity C-reactive protein; AFP, α-fetoprotein; HCC, hepatocellular carcinoma; TNM, tumor-node-metastasis.